glp-1 for obesity kenner Hot take: both sides are oversimplifying GLP-1s. We should be asking harder questions about GLP-1s—research, marketing, long-term outcomes. And yes—some points are valid: • weight loss is variable • regain after stopping GLP-1 Advanced Metabolic Extra Strength
Description
But Medicare covers GLP-1 medications only to treat Type 2 diabetes and for cardiovascular disease that may be worsened by a patient's excess weight

JAMA Surg 151: 798, 2016

H., Al-Kuraishy H
However, current human evidence is derived mainly from metabolic trials and pharmacoepidemiologic studies conducted at approved therapeutic doses, rather than from oncology trials specifically designed to induce tumor apoptosis (174-176)

doi: 10.1002/advs.202104759
